BCL6 and neoplasm: Our results were conceptually in line with recent findings showing that BCL6 enabled tumor cell tolerance to cytotoxic stress (Fernando et al., 2019) and conferred tyrosine kinase inhibitor resistance in Ph+ acute lymphoblastic leukemia (Duy et al., 2011).